Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Adenosine triphosphate injection - Cordex Pharma

Next Previous
X
Search
Drug Profile

Adenosine triphosphate injection - Cordex Pharma

Alternative Names: ATPace

Latest Information Update: 02 Oct 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Duska Therapeutics
  • Developer Cordex Pharma
  • Class Adenine nucleotides; Antiarrhythmics; Diagnostic agents; Infertility therapies; Small molecules
  • Mechanism of Action Purinergic P2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Bradycardia; Paroxysmal supraventricular tachycardia

Most Recent Events

  • 02 Jun 2009 The US FDA approves Special Protocol Assessment (SPA) design of phase IIb/III trials for Paroxysmal supraventricular tachycardia
  • 20 Feb 2009 Cordex Pharma submits to the US FDA an amended phase III trial protocol for Paroxysmal supraventricular tachycardia
  • 20 Nov 2008 Duska Therapeutics applies for a Special Protocol Assessment with the US FDA to conduct a pivotal phase III trial for Paroxysmal supraventricular tachycardia

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top